These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26423177)

  • 1. Ocular safety comparison of non-steroidal anti-inflammatory eye drops used in pseudophakic cystoid macular edema prevention.
    Fernández-Ferreiro A; Santiago-Varela M; Gil-Martínez M; Parada TG; Pardo M; González-Barcia M; Piñeiro-Ces A; Rodríguez-Ares MT; Blanco-Mendez J; Lamas MJ; Otero-Espinar FJ
    Int J Pharm; 2015 Nov; 495(2):680-91. PubMed ID: 26423177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
    Nagai N; Ito Y; Okamoto N; Shimomura Y
    Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Toxicity of Nonsteroidal Anti-inflammatory Eye Drops against Human Corneal Epithelial Cells in Vitro.
    Lee JS; Kim YH; Park YM
    J Korean Med Sci; 2015 Dec; 30(12):1856-64. PubMed ID: 26713063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.
    Tzelikis PF; Vieira M; Hida WT; Motta AF; Nakano CT; Nakano EM; Alves MR
    Br J Ophthalmol; 2015 May; 99(5):654-8. PubMed ID: 25385061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction.
    Weisz JM; Bressler NM; Bressler SB; Schachat AP
    Ophthalmology; 1999 Sep; 106(9):1656-9. PubMed ID: 10485530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac.
    Wolf EJ; Braunstein A; Shih C; Braunstein RE
    J Cataract Refract Surg; 2007 Sep; 33(9):1546-9. PubMed ID: 17720068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
    Trattler W; McDonald M
    Cornea; 2007 Jul; 26(6):665-9. PubMed ID: 17592313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysis.
    Duan P; Liu Y; Li J
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):639-649. PubMed ID: 28130595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent.
    Jones J; Francis P
    Expert Opin Pharmacother; 2009 Oct; 10(14):2379-85. PubMed ID: 19735215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac.
    Lindstrom R; Kim T
    Curr Med Res Opin; 2006 Feb; 22(2):397-404. PubMed ID: 16466612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the in vitro ocular toxicity of the fortified antibiotic eye drops prepared at the Hospital Pharmacy Departments.
    Fernández-Ferreiro A; González-Barcia M; Gil-Martínez M; Santiago Varela M; Pardo M; Blanco-Méndez J; Piñeiro-Ces A; Lamas Díaz MJ; Otero-Espinar FJ
    Farm Hosp; 2016 Sep; 40(5):352-70. PubMed ID: 27570987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on clinical pathophysiology of pseudophakic/aphakic eyes--a journey of 4 decades].
    Miyake K
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):214-45; discussion 246. PubMed ID: 18411712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Evaluation of the Ophthalmic Toxicity Profile of Chlorhexidine and Propamidine Isethionate Eye Drops.
    Fernández-Ferreiro A; Santiago-Varela M; Gil-Martínez M; González-Barcia M; Luaces-Rodríguez A; Díaz-Tome V; Pardo M; Méndez JB; Piñeiro-Ces A; Rodríguez-Ares MT; Lamas MJ; Otero-Espinar FJ
    J Ocul Pharmacol Ther; 2017 Apr; 33(3):202-209. PubMed ID: 28384032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Retinal Diseases.
    Rodrigues EB; Farah ME; Bottós JM; Bom Aggio F
    Dev Ophthalmol; 2016; 55():212-20. PubMed ID: 26502088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients.
    Warren KA; Fox JE
    Retina; 2008; 28(10):1427-34. PubMed ID: 18664937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
    Almeida DR; Khan Z; Xing L; Bakar SN; Rahim K; Urton T; El-Defrawy SR
    J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review.
    Gaynes BI; Fiscella R
    Drug Saf; 2002; 25(4):233-50. PubMed ID: 11994027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.
    Heier JS; Awh CC; Busbee BG; Waterbury LD; Daniel P; Stoller GL; Cleary TS
    Retina; 2009 Oct; 29(9):1310-3. PubMed ID: 19934822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation.
    Miyake K; Nishimura K; Harino S; Ota I; Asano S; Kondo N; Miyake S
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5647-52. PubMed ID: 18055815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: a phase II, randomized, double-masked trial.
    Colin J; Paquette B
    Clin Ther; 2006 Apr; 28(4):527-36. PubMed ID: 16750464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.